Whitepapers/App Notes/Posters

Case study: Upgrade of an existing sterile production room of freeze-dried vaccines to comply with the requirements of the new GMP annex 1

Posted: 25 November 2020 | | No comments yet

Challenges in day to day operations. The battle of performance in production.

A B S T R A C T

Many pharmaceutical companies have Freeze Dryers in their plants with manual loading and unloading procedures. For most cases, they are using old but reliable equipment. This means that the loading of the containers from the filling line to the freeze dryer and the unloading from the freeze dryer to the capping machine is done manually in an ISO 5 clean room with the main door of the lyophilizer open and with trays containing the primary containers (normally vials or ampoules). With the expected new release of GMP Annex 1, there is an increasing need to upgrade these processes to guaranty the strictest conditions in all operating phases inside the sterile rooms. Instead of relying on the clean room classification, the use of passive or active laminar airflow trolleys together with RABS (restricted area barrier systems) for the movement of the trays with the product containers, avoids product exposure to operators and reduces the operator’s movements. Still the interface with these loading devices and the lyophilizer shelves through a full open door is a potential issue. The solution set out below has helped to ensure that from the outlet of the filling line to the freeze dryer loading/unlading door and from there to the capping machine, the vial trays are always inside an open RABs with particle contamination control and never in contact with the production operators.

Customer

Parenteral Product Manufacturer

Challenge

The pharmaceutical company, a European vaccine producer, currently had one LYOMEGA LM100-ST Freeze Dryer installed in 1995 with a big main door opening into the clean room, served by a filling machine and a capping machine in the same classified ISO5 room.

    To read this case study in full, please complete the form below:

     









    This specialist content is provided to you free-of-charge thanks to the kind support of Telstar

    By clicking submit you confirm that you accept our terms and conditions and privacy policy.

    Related organisations

    Leave a Reply

    Your email address will not be published. Required fields are marked *